Pediatric gastroesophageal reflux disease-current perspectives

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 11, Issue 6, 2003, Pages 447-451

  Strople, Jennifer ^a   Kaul, Ajay ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Endoluminal therapy; Esophageal impedance; Pediatric gastroesophageal reflux disease; TLESR; Transient lower esophageal sphincter relaxation

Indexed keywords

BACLOFEN; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ESOPHAGUS MANOMETRY; GASTROESOPHAGEAL REFLUX; HUMAN; IMPEDANCE; PH MEASUREMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; STOMACH FUNDOPLICATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT;

EID: 0344984260     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200312000-00007     Document Type: Review

References (44)

1. Tasker A, Dettmar PW, Panetti M, et al.: Reflux of gastric juice and glue ear in children. Lancet 2002, 359:493.
2. Nelson SP, Chen EH, Syniar GM, et al.: Prevalence of symptoms of gastroesophageal reflux during infancy. Arch Pediatr Adolesc Med 1997, 151:569-572.
3. Nelson SP, Chen EH, Syniar GM, et al.: One-year follow-up of symptoms of gastroesophageal reflux during infancy. Pediatrics 1998, 102:E67.
4. Nelson SP, Chen EH, Syniar GM, et al.: Prevalence of symptoms of gastroesophageal reflux during childhood. Arch Pediatr Adolesc Med 2000, 154:150-154.
5. Locke GR, Talley NJ, Fett SL, et al.: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112:1448-1456.
6. Dent J, Dodds WJ, Friedman RH, et al.: Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980, 65:256-267.
7. Dodds WJ, Dent J, Hogan WJ, et al.: Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982, 307:1547-1552.
8. Mittal RK, McCallum RW: Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology 1988, 95:593-599.
9. Kawahara H, Dent J, Davidson G: Mechanisms responsible for gastroesophageal reflux in children. Gastroenterology 1997, 113:399-408.
10. Mittal RK, Holloway RH, Penagini R, et al.: Transient lower esophageal sphincter relaxation. Gastroenterology 1995, 109:601-610.
11. Hirsch DP, Tytgat GNJ, Boeckxstaens GEE: Review article: transient lower oesophageal sphincter relaxations-a pharmacological target for gastrooesophageal reflux disease. Aliment Pharmacol Ther 2002, 16:17-26.
12. Rudolph CD, Mazur LJ, Liptak GS, et al.: Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001, 32(Suppl 2):S1-31. A comprehensive review of the current literature on pediatric gastroesophageal reflux disease with algorithms for evaluation and management.
13. Colletti RB, Christie DL, Orenstein SR: Statement of the North American Society for Pediatric Gastroenterology and Nutrition (NASPGN). Indications for pediatric esophageal pH monitoring. J Pediatr Gastroenterol Nutr 1995, 21:253-262.
14. Gremse DA: Gastroesophageal reflux disease in children: an overview of pathophysiology, diagnosis, and treatment. J Pediatr Gastroenterol Nutr 2002, 35(Suppl 4):S297-S299.
15. Jacob P, Kahrilas PJ, Herzon G: Proximal esophageal pH-metry in patients with 'reflux laryngitis'. Gastroenterology 1991, 100:305-310.
16. Rabinowitz SS, Piecuch S, Jibaly R, et al.: Optimizing the diagnosis of gastroesophageal reflux in children with otolaryngologic symptoms. Int J Pediatr Otorhinolaryngol 2003, 67:621-626.
17. Skopnik H, Silny J, Heiber O, et al.: Gastroesophageal reflux in infants: evaluation of a new intraluminal impedance technique. J Pediatr Gastroenterol Nutr 1996, 23:591-598.
18. Wenzl TG, Moroder C, Trachterna M, et al.: Esophageal pH monitoring and impedance measurement: a comparison of two diagnostic tests for gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2002, 34:519-523.
19. Wenzl TG: Investigating esophageal reflux with the intraluminal impedance technique. J Pediatr Gastroenterol Nutr 2002, 34:261-268. A good review of intraluminal impedance measurements, focusing of the clinical applications of this technique in both adults and pediatric patients.
20. Silny J: Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil 1991, 3:151-162.
21. Sifrim D, Holloway R, Silny J, et al.: Acid, nonacid and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001, 120:1588-1598. Using impedance measurements, the study evaluates the frequency of acid and nonacid reflux in both healthy subjects and patients with GERD. Although the total number of reflux events was similar in both groups, patients with GERD had significantly more acid reflux.
22. Pandolfino JE, Richter JE, Ours T, et al.: Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003, 98:740-749.
23. Squires RH, Colletti RB: Indications for pediatric gastrointestinal endoscopy: a medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1996, 23:107-110.
24. Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991, 101:1-78.
25. Belafsky PC, Postma GN, Koufman JA: The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001, 111:1313-1317.
26. Fox VL, Nurko S, Furuta GT: Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc 2002, 56:260-270. An excellent review of the available literature on eosinophilic esophagitis. This paper examines the epidemiology, clinical features, endoscopic findings, and current treatments for this disease.
27. Biller JA, Winter HS, Grand RJ, et al.: Are endoscopic changes predictive of histologic esophagitis in children? J Pediatr 1983, 103:215-218.
28. Chiba N, De Gara CJ, Wilkinson JM, et al.: Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997, 112:1798-1810.
29. Hassall E, Israel D, Shepherd R, et al.: Omeprazole for treatment of chronic erosive esophagitis in children: a mutticenter study of efficacy, safety, tolerability and dose requirements. J Pediatr 2000, 137:800-807.
30. Andersson T, Hassall E, Lundborg P, et al.: Pharmacokinetics of orally administered omeprazole in children. Am J Gastroenterol 2000, 95:3101-3106.
31. Faure C, Michaud L, Shaghaghi EK, et al.: Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis. Aliment Pharmacol Ther 2001, 15:1397-1402.
32. Blackshaw LA, Staunton E, Lehmann A, et al.: Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonist. Am J Physiol 1999, 277:G867-G874.
33. B receptor inhibits transient lower esophageal sphincter relaxation in dogs. Gastroenterology 1999, 117:1147-1154.
34. B agonist baclofen in normal subjects. Gastroenterology 2000, 118:7-13.
35. B agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002, 50:19-24. A randomized placebo-controlled crossover trial of the effects of baclofen in patients with reflux disease. Results from this and similar studies may lead to the development of more targeted drug therapy for gastroesophageal reflux disease.
36. Vela MF, Tutuian R, Katz PO, et al.: Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003, 17:243-251.
37. Wiersma HE, van Boxtel CJ, Butter JJ, et al.: Pharmacokinetics of a single oral dose of baclofen in pediatric patients with gastroesophageal reflux disease. Ther Drug Monit 2003, 25:93-98.
38. Di Lorenzo C, Orenstein S: Fundoplication: friend or foe. J Pediatr Gastroenterol Nutr 2002, 34:117-124.
39. Mattioli G, Repetto P, Carlini C, et al.: Laparoscopic vs open approach for the treatment of gastroesophageal reflux in children. Surg Endosc 2002, 16:750-752.
40. Blewett CJ, Hollenbeak CS, Cilley RE, et al.: Economic implications of current surgical management of gastroesophageal reflux disease. J Pediatr Surg 2002, 37:427-430.
41. DiBaise JK, Brand RE, Quigley EMM: Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action. Am J Gastroenterol 2002, 97:833-842.
42. Galmiche JP: des Varannes SB: Endoluminal therapies for gastrooesophageal reflux disease. Lancet 2003, 361:1119-1121. A succinct review of the current literature on endoluminal procedures for gastroesophageal reflux disease, focusing on the Stretta and Endocinch techniques.
43. Filipi CJ, Lehman GA, Rothstein RI, et al.: Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial. Gastrointest Endosc 2001, 53:416-422.
44. Mahmood Z, McMahon BP, Arfin Q, et al.: Endocinch therapy for gastrooesophageal reflux disease: a one year prospective follow up. Gut 2003, 52:34-39.